Etizolam

Etizolam

SCHEMBL28142121

CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl.CN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 3/20 0.69
PDE4D Q08499 2/20 0.69
GABRA1 P14867 1/20 0.58
GABRG2 P18507 1/20 0.58
HTR2A P28223 1/20 0.58
GABRB3 P28472 1/20 0.58
GABRA5 P31644 1/20 0.58
GABRA3 P34903 1/20 0.58
ADRA1A P35348 1/20 0.58
GABRA2 P47869 1/20 0.58
PTAFR P25105 17/20 0.54
CYP3A4 P08684 1/20 0.51
ALOX15 P16050 1/20 0.51
HTR1A P08908 1/20 0.50
DRD3 P35462 1/20 0.50
HTR3A P46098 1/20 0.50
KCNH2 Q12809 1/20 0.50
GHSR Q92847 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fletazepam SCHEMBL1004270 0.92 OPRK1 (0.57) OPRK1PDE4DGABRA1GABRG2HTR2A
Etizolam SCHEMBL28086661 0.86 OPRK1 (0.85) OPRK1PDE4DPTAFRCYP3A4ALOX15
SCHEMBL8928407 0.84 OPRK1 (0.79) OPRK1PDE4DGABRA1GABRA5GABRA2
Etizolam SCHEMBL42920 0.83 OPRK1 (1.00) OPRK1PDE4DPTAFRCYP3A4ALOX15
Etizolam SCHEMBL30665015 0.83 OPRK1 (1.00) OPRK1PDE4DPTAFRCYP3A4ALOX15
Etizolam SCHEMBL10869413 0.80 OPRK1 (0.90) OPRK1PDE4DPTAFRCYP3A4ALOX15
Triazolam SCHEMBL5967518 0.80 GABRA1 (0.75) OPRK1PDE4DGABRA1GABRG2HTR2A
Flurazepam SCHEMBL6130059 0.80 OPRK1 (0.76) OPRK1PDE4DGABRA1GABRG2HTR2A
Fludiazepam SCHEMBL29564860 0.78 GABRA1 (0.72) OPRK1PDE4DGABRA1GABRG2GABRB3
Fludiazepam SCHEMBL29440251 0.78 GABRA1 (0.72) OPRK1PDE4DGABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103717597-B Heterocyclic compounds as kinase inhibitors 原真股份有限公司 2017-07-04 CN disclosed